Danone's Revenues Struggle to Meet Volumes

Danone may struggle to raise prices but we think it's positioned to achieve solid growth in the medium term

Philip Gorham, CFA 15 April, 2010 | 5:22PM
Facebook Twitter LinkedIn

Danone's first-quarter sales report supports our thesis that stiff competition in the dairy industry will make it difficult to raise prices. However, the firm is positioned in health and wellness categories that should allow it to achieve solid growth in the medium term, and we are maintaining our EUR 35 fair value estimate.

On a constant currency basis, first-quarter revenue grew 7% from the same period a year ago, led by higher volume in health and wellness categories. The baby and medical nutrition segments were particularly strong, with volume growing 9% and 8%, respectively. However, for the second consecutive quarter Danone's revenue did not grow at the same pace as volume because the company cut prices in its dairy segment. As the cost of dairy commodities fell in 2009, manufacturers were forced to lower prices to consumers, an indication of the industry's intense competitive environment. Although we expect retail prices to rebound along with commodity inflation as the economy recovers, the competitive nature of the industry should prevent significant margin expansion.

Despite Danone's presence in the highly competitive dairy and bottled water industries, we like the firm's portfolio of functional foods. We expect further consumer migration to health and wellness products to benefit Danone in the long term.

Philip Gorham, CFA is a Morningstar equity analyst.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Philip Gorham, CFA  Philip Gorham, CFA, is an associate director of equity research for Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures